← Leaderboards
Rachel G Sinkey
University Of Alabama At Birmingham
$1,479,223
Attributed
$3,436,267
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,436,267 · 3
By mechanism
U01$2,011,151 · 1
K23$728,870 · 1
R01$696,246 · 1
Top collaborators
- Rebecca Gersnoviez Clifton1 shared
- Laurie Beth Griffin1 shared
- Jennifer S Guimbellot1 shared
- Dwight J Rouse1 shared
- Alan Thevenet N. Tita1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Alan Thevenet N. Tita$31,628,801
- Renee A. Heffron$19,065,543
- Benjamin H Chi$27,017,926
- Dwight J Rouse$18,107,824
- William Walton Andrews$7,280,922
Others in their field
Other Rising Stars on “Pregnant Women”
- Hong-Ngoc B. Nguyen · University Of Minnesota$6,812,121
- Cindy S Chu · University Of Oxford$3,588,034
- Sierra E Carter · Emory University$3,360,000
- Cassandra R. Newsom · University Of Alabama At Birmingham$3,160,101
- Sunni L. Mumford · University Of Pennsylvania$2,959,848
- Teresa N Sparks · University Of California, San Francisco$2,851,643
Research focus
Pregnant WomenMothersPregnancyAffectOpen LabelMaternal-Fetal MedicineNeonatalPostpartum PeriodWomanLifeFetusPharmaceutical PreparationsAmerican Heart AssociationAmerican College Of Obstetricians And GynecologistsLiver DysfunctionIntraventricular HemorrhageBirthHypertensionMasksAwardFoundationsBronchopulmonary DysplasiaBlood PressureFuture
Grant awards (6)
Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST Trial$2,011,151
U01 · FY2025 · HD
Evaluating Maternal and Neonatal Pharmacokinetics of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators - The ELECTRA Pregnancy Study$696,246
R01 · FY2025 · HD
The ACHIEVE Trial: Achieving longer gestation in preeclampsia via antihypertensive therapy.$154,742
K23 · FY2025 · HL · contact PI
The ACHIEVE Trial: Achieving longer gestation in preeclampsia via antihypertensive therapy.$191,376
K23 · FY2024 · HL · contact PI
The ACHIEVE Trial: Achieving longer gestation in preeclampsia via antihypertensive therapy.$191,376
K23 · FY2023 · HL · contact PI
The ACHIEVE Trial: Achieving longer gestation in preeclampsia via antihypertensive therapy.$191,376
K23 · FY2022 · HL · contact PI